Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FAP-1 Study: FAPi PET in Pancreatic Ductal Adenocarcinoma: A Prospective, Exploratory Study

NCT07342231 is registered in ClinicalTrials.gov with Tata Memorial Hospital as lead sponsor.

NCT NCT07342231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07342231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FAP-1 Study: FAPi PET in Pancreatic Ductal Adenocarcinoma: A Prospective, Exploratory Study
Lead sponsor
Tata Memorial Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 4, 2025
Completion date
January 1, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma pancreas, pancreatic cancer